Cryptobiotix

Gent ·KBO/BCE: BE 0762.565.104

Loading dossier…

Metric	This company	Sector median	Position in the sector
Solvency	46.8%	29.7%	better than 61% of 38 sector peers
Net result	€1.18M	€-80k	better than 95% of 37 sector peers
Equity	€1.98M	€82k	better than 80% of 38 sector peers
Gross operating margin	€2.47M	€-2k	better than 95% of 38 sector peers
Total assets	€4.23M	€671k	better than 76% of 38 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€4.23M
Fixed assets	21/28	€275k
Intangible fixed assets	21	€61k
Tangible fixed assets	22/27	€208k
Financial fixed assets	28	€6k
Current assets	29/58	€3.95M
Stocks & contracts in progress	3	€115k
Amounts receivable within one year	40/41	€1.55M
Cash & bank	54/58	€2.27M
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€4.23M
Equity	10/15	€1.98M
Contributions / capital	10/11	€62k
Reserves	13	€1.92M
Amounts payable	17/49	€2.25M
Amounts payable after one year	17	€87k
Amounts payable within one year	42/48	€912k
Trade debts payable within one year	44	€423k
Income statement
Gross operating margin	9900	€2.47M
Operating result	9901	€1.49M
Financial income	75	€32k
Financial charges	65	€18k
Result before taxes	9903	€1.51M
Income taxes	67/77	€329k
Net result for the period	9904	€1.18M
Result to be appropriated	9905	€1.18M

NACE primary	Speur- en ontwikkelingswerk op biotechnologisch gebied(72101)
Legal form	Public limited company(014)
Incorporation	27-01-2021
Status	Active
Postal code	9052

Summary